The Journal of Experimental Medicine
Avanti Polar Lipids, Inc.
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published 5 July 2005. doi:10.1084/jem.20050198
Rockefeller University Press, 0022-1007 $8.00
JEM, Volume 202, Number 1, 73-84
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 1809K)
Right arrow PPT slides of all figures
Right arrow Supplemental Material Index
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Logunova, N. N.
Right arrow Articles by Chervonsky, A. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Logunova, N. N.
Right arrow Articles by Chervonsky, A. V.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

ARTICLE

Restricted MHC–peptide repertoire predisposes to autoimmunity

Nadezda N. Logunova1, Christophe Viret2, Leonid A. Pobezinsky1, Sara A. Miller1, Dmitri B. Kazansky3, John P. Sundberg1, and Alexander V. Chervonsky1

1 The Jackson Laboratory, Bar Harbor, ME 04609
2 Section of Immunobiology, Yale University, New Haven, CT 06520
3 Cancer Research Center, Moscow 115478, Russia

CORRESPONDENCE Alexander Chervonsky: avc{at}jax.org

MHC molecules associated with autoimmunity possess known structural features that limit the repertoire of peptides that they can present. Such limitation gives a selective advantage to TCRs that rely on interaction with the MHC itself, rather than with the peptide residues. At the same time, negative selection is impaired because of the lack of negatively selecting peptide ligands. The combination of these factors may predispose to autoimmunity. We found that mice with an MHC class II–peptide repertoire reduced to a single complex demonstrated various autoimmune reactions. Transgenic mice bearing a TCR (MM14.4) cloned from such a mouse developed severe autoimmune dermatitis. Although MM14.4 originated from a CD4+ T cell, dermatitis was mediated by CD8+ T cells. It was established that MM14.4+ is a highly promiscuous TCR with dual MHC class I/MHC class II restriction. Furthermore, mice with a limited MHC–peptide repertoire selected elevated numbers of TCRs with dual MHC class I/MHC class II restriction, a likely source of autoreactivity. Our findings may help to explain the link between MHC class I responses that are involved in major autoimmune diseases and the well-established genetic linkage of these diseases with MHC class II.


Abbreviations used: ANA, antinuclear antibody; dr-TCR, dual–MHC-restricted TCR; Ii, invariant chain.

N.N. Logunova, C. Viret, and L.A. Pobezinsky contributed equally to this work.

C. Viret's present address is Institut National de la Santé et de la Recherche Medicale Unit 548 and CEA-DRDC, 38054 Grenoble Cedex 9, France.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS